Why the study?
The incidence of thrombosis is increasing with aging societies, and ADP-mediated platelet activation via P2Y12 plays a central role in atherothrombosis, with genetic polymorphisms affecting clopidogrel metabolism raising clinical discussion.
Answers are grounded in this paper and cite their sources.
This review discusses the role of P2Y12 receptors in atherothrombosis and the clinical impact of cytochrome P450 genetic polymorphisms on clopidogrel metabolism.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yoshiaki Tomiyama (2012) conducted a review in Atherothrombosis. P2Y12 inhibitors and CYP2C19 genotyping was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: